HM 12480
Alternative Names: LAPSInsulin 148; HM-12480Latest Information Update: 04 Apr 2022
At a glance
- Originator Hanmi Pharmaceutical
- Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 04 Apr 2022 Discontinued - Preclinical for Diabetes mellitus in South Korea (Parenteral) (Hanmi Pharmaceutical pipeline, April 2022)